ABSTRACT:
Pulmonary tuberculosis is a serious infection caused by the bacterium Mycobacterium tuberculosis that involves the lungs but may spread to other organs. TB is a contagious disease that can infect anyone exposed to MTB. Pulmonary tuberculosis (TB) remains one of the world’s most challenging infectious diseases, affecting millions each year and contributing to high morbidity and mortality rates globally. A total of 1.25 million people died from tuberculosis (TB) in 2023 (including 161 000 people with HIV). The goal of latent TB infection treatment is to prevent progression to active disease. Given that most patients will not reactivate during their lifetime if untreated, the risk of this progression must be balanced against the risk of toxicity from treatment, particularly hepatotoxicity with isoniazid-based therapy. The majority of sample’s age is between 31-40 years, Duration of illness 6months to 1 Year, Pulmonary TB, with present family History, and hospitalization. The obtained t-test for the level of knowledge calculated t-value was (-18.52) and tabulated t-value was 2.02. Thus shows very highly significant at p<0.05 level.
Cite this article:
Suneesh P M. A Study to Assess Effectiveness of Planned Teaching Programme on Knowledge regarding Prevention and Management of Complications of Tuberculosis among patients with Pulmonary TB in selected hospital at Rajkot. International Journal of Advances in Nursing Management. 2026;14(3):163-5. doi: 10.52711/2454-2652.2026.00034
Cite(Electronic):
Suneesh P M. A Study to Assess Effectiveness of Planned Teaching Programme on Knowledge regarding Prevention and Management of Complications of Tuberculosis among patients with Pulmonary TB in selected hospital at Rajkot. International Journal of Advances in Nursing Management. 2026;14(3):163-5. doi: 10.52711/2454-2652.2026.00034 Available on: https://ijanm.com/AbstractView.aspx?PID=2026-14-3-8
REFERENCE:
1. Cleveland clinic9500 Euclid Avenue, Cleveland, Ohio 44195 800.223.2273https://my.clevelandclinic.org/health/body/21205-respiratory-system
2. Hansen-Flaschen, John, Bates, David V. "respiratory disease". Encyclopedia Britannica, 2 May. 2025, https://www.britannica.com/science/respiratory-disease. Accessed 11 June 2025.
3. Houston Methodust Leading Medicine, Tuberculosis Symptoms and Treatment Options, https://www.houstonmethodist.org/pulmonology/tuberculosis/
4. Price C, Nguyen AD. Latent Tuberculosis. [Updated 2024 Jan 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-.
5. World health organization, available at https://www.who.int/news-room/fact-sheets/detail/tuberculosis
6. Floyd K, Glaziou P, Houben R, Sumner T, White RG, Raviglione M. Global tuberculosis targets and milestones set for 2016-2035: definition and rationale. Int J Tuberc Lung Dis. 2018; 22(7): 723-30.
7. Cardona PJ. Pathogenesis of tuberculosis and other mycobacteriosis. Enferm Infecc Microbiol Clin (Engl Ed). 2018 Jan; 36(1): 38-46. English, Spanish. doi: 10.1016/j.eimc.2017.10.015. Epub 2017 Dec 2. PMID: 29198784